Dose escalation for locally advanced pancreatic cancer: How high can we go? by Lauren E. Colbert, MD, Neal Rebueno, CMD, Shalini Moningi, MD, Sam Beddar, PhD, Gabriel O. Sawakuchi, PhD, Joseph M. Herman, MD, Albert C. Koong, MD, PhD, Prajnan Das, MD, Emma B. Holliday, MD, Eugene J. Koay, MD, PhD, Cullen M. Taniguchi, MD, PhD

Get full text

Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC by Lauren E. Colbert, MD, MSCR, Shalini Moningi, MD, Awalpreet Chadha, MD, Ahmed Amer, MD, Yeonju Lee, PhD, Robert A. Wolff, MD, Gauri Varadhachary, MD, Jason Fleming, MD, Matthew Katz, MD, Prajnan Das, MD, MPH, Sunil Krishnan, MD, Eugene J. Koay, MD, PhD, Peter Park, PhD, Christopher H. Crane, MD, Cullen M. Taniguchi, MD, PhD

Get full text